Switching diabetes treatment after short insulin therapy
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at what happens when people with type 2 diabetes switch from a short course of intensive insulin therapy to different daily diabetes medicines. It aims to find which option helps keep blood sugar under control and might be easier for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You have had type 2 diabetes for more than 1 year but less than 15 years.
- You are currently taking at least one diabetes pill (like metformin) and have been on the same dose for at least 3 months.
- Your blood sugar (measured by HbA1c) must be above a certain level: above 8.0% if you take one pill, above 7.5% if you take more than one.
- Your body mass index (BMI) must be between 20 and 35.
- You must agree to use an insulin pen or pump for a short period, wear a continuous glucose monitor, and follow lifestyle advice.
- You must be willing to use effective birth control during the study if you could become pregnant.
- You must not have taken certain diabetes injectable medicines (like GLP-1 agonists) in the last 3 months, and you must not have had intensive insulin therapy in the past year.
- You must not have severe diabetes complications, such as advanced eye or kidney problems, or recent heart attacks or strokes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether switching from a FreeStyle Libre 2 (which you scan to check sugar) to a Dexcom G7 (which sends sugar readings automatically to your phone) can improve blood sugar control in adults with type 2 diabetes who use insulin.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study tests whether switching from a common diabetes medication, dulaglutide, to a new one called PG-102 is safe and works well for people with type 2 diabetes. It looks at how the new drug manages blood sugar and any side effects.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
This study compares two types of long-acting insulin: a newer one called Glargine and an older one called NPH. You'll use a continuous glucose monitor to track your blood sugar, and the study will see which insulin helps control your diabetes better with fewer side effects.
This study tests a new once-weekly insulin shot (icodec) compared to daily long-acting insulins for people with type 2 diabetes whose blood sugar is not well controlled on their current non-insulin medications.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.